BSF Enterprise Plc

BSF Enterprise shares soared 56.5% to 1.33 pence after the tissue engineering company agreed outline terms for a joint venture to sell its lab-grown leather into the American luxury market. The London-listed group signed non-binding heads of terms with US brand operator IMPOSTER to form a 50/50 venture, with BSF contributing technology licensing and material supply while IMPOSTER provides operational funding of between 500,000 and 1 million dollars drawn from a planned 3.5 million dollar growth capital raise. Full commercial exclusivity for the venture only activates once that funding is received. The venture will focus on small luxury items such as bag charms, keyrings, desk accessories, equestrian goods, and a limited run of bespoke handbags and wallets, while BSF retains all intellectual property and commercial rights in higher-volume categories including mainline footwear, apparel, automotive interiors, and mass-market handbags. BSF is targeting three revenue streams: a gross margin of 25 to 35 percent on raw material transfers, a royalty of 3 to 7 percent on net sales, and half of any venture profits.